These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8845013)

  • 1. Effects of methylnaltrexone on morphine-induced cough suppression in guinea pigs.
    Foss JF; Orelind E; Goldberg LI
    Life Sci; 1996; 59(15):PL235-8. PubMed ID: 8845013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid-induced delay in gastric emptying: a peripheral mechanism in humans.
    Murphy DB; Sutton JA; Prescott LF; Murphy MB
    Anesthesiology; 1997 Oct; 87(4):765-70. PubMed ID: 9357876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylnaltrexone prevents morphine-induced kaolin intake in the rat.
    Aung HH; Mehendale SR; Xie JT; Moss J; Yuan CS
    Life Sci; 2004 Apr; 74(22):2685-91. PubMed ID: 15043984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone.
    Beattie DT; Cheruvu M; Mai N; O'Keefe M; Johnson-Rabidoux S; Peterson C; Kaufman E; Vickery R
    Naunyn Schmiedebergs Arch Pharmacol; 2007 May; 375(3):205-20. PubMed ID: 17340127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine.
    Yuan CS; Foss JF; Moss J
    Eur J Pharmacol; 1995 Mar; 276(1-2):107-11. PubMed ID: 7781680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial.
    Yuan CS; Foss JF; O'Connor M; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1996 Apr; 59(4):469-75. PubMed ID: 8612393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; O'Connor M; Karrison T; Osinski J; Roizen MF; Moss J
    Clin Pharmacol Ther; 2000 Apr; 67(4):398-404. PubMed ID: 10801249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs.
    Foss JF; Bass AS; Goldberg LI
    J Clin Pharmacol; 1993 Aug; 33(8):747-51. PubMed ID: 8408737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial.
    Yuan CS; Wei G; Foss JF; O'Connor M; Karrison T; Osinski J
    J Pharmacol Exp Ther; 2002 Jan; 300(1):118-23. PubMed ID: 11752106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; Osinski J; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1997 Apr; 61(4):467-75. PubMed ID: 9129564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute exposure to saccharin reduces morphine analgesia in the the rat: evidence for involvement of N-methyl-D-aspartate and peripheral opioid receptors.
    McNally GP; Westbrook RF
    Psychopharmacology (Berl); 2000 Mar; 149(1):56-62. PubMed ID: 10789883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of heroin and morphine self-administration in rats by the morphine-6beta-glucuronide antagonist 3-O-methylnaltrexone.
    Walker JR; King M; Izzo E; Koob GF; Pasternak GW
    Eur J Pharmacol; 1999 Oct; 383(2):115-9. PubMed ID: 10585524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects.
    Yuan CS; Israel RJ
    Expert Opin Investig Drugs; 2006 May; 15(5):541-52. PubMed ID: 16634692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of morphine and methylnaltrexone on gastrointestinal pain in healthy male participants.
    Brokjaer A; Olesen AE; Christrup LL; Dahan A; Drewes AM
    Neurogastroenterol Motil; 2015 May; 27(5):693-704. PubMed ID: 25810023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of methylnaltrexone on guinea pig gastrointestinal motility.
    Anselmi L; Huynh J; Vegezzi G; Sternini C
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Apr; 386(4):279-86. PubMed ID: 23361094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central vs. peripheral mediation of opioid effects on alcohol consumption in free-feeding rats.
    Linseman MA
    Pharmacol Biochem Behav; 1989 Jun; 33(2):407-13. PubMed ID: 2813479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytes.
    Ho WZ; Guo CJ; Yuan CS; Douglas SD; Moss J
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1158-62. PubMed ID: 14560041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylnaltrexone crosses the blood-brain barrier and attenuates centrally-mediated behavioral effects of morphine and oxycodone in mice.
    Walentiny DM; Komla E; Moisa LT; Mustafa MA; Poklis JL; Akbarali HI; Beardsley PM
    Neuropharmacology; 2021 Mar; 185():108437. PubMed ID: 33316279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects.
    Yuan CS
    Ann Pharmacother; 2007 Jun; 41(6):984-93. PubMed ID: 17504835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of morphine-induced catalepsy in the rat by narcotic antagonists and their quaternary derivatives.
    Brown DR; Robertson MJ; Goldberg LI
    Neuropharmacology; 1983 Mar; 22(3):317-21. PubMed ID: 6682490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.